𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HGF/MET rescues Gefitinib treated non-small cell lung cancer cells carrying an activating EGFR mutation

✍ Scribed by Mark Y. Sun; Thomas Bachleitner-Hofmann; Chin-Tung Chen; David B. Solit; Martin R. Weiser


Book ID
113678800
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
61 KB
Volume
207
Category
Article
ISSN
1072-7515

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Gefitinib or Chemotherapy for Non–Small-
✍ Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, πŸ“‚ Article πŸ“… 2010 πŸ› Massachusetts Medical Society 🌐 English βš– 341 KB

## Background: Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (egfr) is highly responsive to egfr tyrosine kinase inhibitors such as gefitinib, but little is known about how its efficacy and safety profile compares with that of standard chemotherapy. ##